Table 2.
Group | Analyte | Vd (L/kg) | Protein binding (%) | Potency relative to morphine | References |
---|---|---|---|---|---|
Natural and semi-synthetic opioids | Morphine | 1–6 | 30–40 | 1 | Baselt, 2017 |
Codeine | 2.5–3.5 | 7–25 | 0.3 | Baselt, 2017 | |
Hydrocodone | 3.3–4.7 | 19–45 | 0.5–1 | Patanwala et al., 2007; Baselt, 2017 | |
Hydromorphone | 2.9 | 20 | 5–10 | Bruera et al., 1996; Patanwala et al., 2007; Baselt, 2017 | |
Oxycodone | 2.6 | 45 | 1 | Patanwala et al., 2007; Al-Asmari et al., 2009 | |
Oxymorphone | 3 | 10–12 | 10 | Patanwala et al., 2007; Smith, 2009 | |
Buprenorphine | 3–5 | 96 | 40 | Dahan et al., 2005 | |
Synthetic opioids | Fentanyl | 3–8 | 80–85 | 224 | Jumbelic, 2010 |
Methadone | 1–8 | 85–90 | 3–5 | Patanwala et al., 2007; Baselt, 2017 | |
Tramadol | 3 | 20 | 0.1 | Christoph et al., 2007; Oertel et al., 2011 | |
Synthetic opioids-Fentanyl derivatives | Acetylfentanyl | NA | NA | 15 | Higashikawa and Suzuki, 2008 |
Acrylfentanil | NA | NA | 170 | Ujváry et al., 2017 | |
Alfentanil | 0.4–1 | 92 | 72 | Vardanyan and Hruby, 2014 | |
Butyryl fentanyl; butyr fentanyl | NA | NA | 7 | Higashikawa and Suzuki, 2008 | |
Isobutyrylfentanyl | NA | NA | 1.3–6.9 | Higashikawa and Suzuki, 2008 | |
Carfentanil | NA | NA | 10,000 | Van Bever et al., 1976 | |
Furanyl fentanyl | NA | NA | 7 | Higashikawa and Suzuki, 2008 | |
alpha-methylfentanyl | NA | NA | 56.9 | Higashikawa and Suzuki, 2008 | |
cis-3-methylfentanyl; 3-MF; mefentanyl | NA | NA | 6000 | Higashikawa and Suzuki, 2008 | |
Remifentanil | 0.35 | 70 | 220 | Wax et al., 2003 | |
Sufentanil | NA | NA | 4,520 | Niemegeers et al., 1976 | |
Synthetic opioids-Not related to fentanyl | AH-7921 | NA | NA | 1 | Hayes and Tyers, 1983 |
U-47700 | NA | NA | 7.5 | Cheney et al., 1985 | |
MT-45 | NA | NA | 1 | EMCDDA, 2015 |
NA, not available.